What role does Cardio Risk Check play in longevity?

A Cardio Risk Check (CRC) combines classical biomarkers (cholesterol, blood pressure, inflammation) with genetic risk variants (e.g., SLCO1B1 for statin side effects, TCF7L2 for diabetes). For longevity, early detection and management of cardiovascular risk is crucial, as heart disease remains the leading cause of death worldwide. Evidence for individual genetic markers is moderate: GWAS show associations, but effect sizes are small and polygenic risk scores have limited individual predictive power. A CRC can motivate targeted lifestyle changes (diet, exercise, smoking cessation) and guide drug choice if statins are needed. Importantly, a positive risk report is not a diagnosis; most risk carriers remain healthy. The CRC is a preventive tool, not a longevity guarantee. Evidence: human‑moderate (for biomarkers) to gwas (for genetic components).